{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "ARDS",
      "COVID-19",
      "NETs",
      "histidine-rich glycoprotein",
      "immunothrombosis",
      "inter-alpha inhibitor proteins"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33841442",
  "DateCompleted": {
    "Year": "2021",
    "Month": "04",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "04",
    "Day": "19"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "03",
        "Day": "24"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "656099",
      "10.3389/fimmu.2021.656099"
    ],
    "Journal": {
      "ISSN": "1664-3224",
      "JournalIssue": {
        "Volume": "12",
        "PubDate": {
          "Year": "2021"
        }
      },
      "Title": "Frontiers in immunology",
      "ISOAbbreviation": "Front Immunol"
    },
    "ArticleTitle": "Understanding of COVID-19 Pathology: Much More Attention to Plasma Proteins.",
    "Pagination": {
      "StartPage": "656099",
      "MedlinePgn": "656099"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."
          }
        ],
        "LastName": "Nishibori",
        "ForeName": "Masahiro",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatrics, Women & Infants Hospital of Rhode Island, The Alpert Medical School of Brown University, Providence, RI, United States."
          }
        ],
        "LastName": "Stonestreet",
        "ForeName": "Barbara S",
        "Initials": "BS"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 HD057100",
        "Acronym": "HD",
        "Agency": "NICHD NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R21 NS095130",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R21 NS096525",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R44 NS084575",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Front Immunol",
    "NlmUniqueID": "101560960",
    "ISSNLinking": "1664-3224"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Blood Proteins"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Blood Proteins"
    },
    {
      "QualifierName": [
        "immunology",
        "pathology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
}